Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Graham Parry currently holds 85,504 shares of Electra Therapeutics, Inc. (ETRA), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Graham Parry has been a net neutral trader of ETRA stock. They have purchased $0 and sold $0 worth of shares.
Graham Parry's most recent insider trade was on Sep 21, 2026, when they sold 85,504 shares at $0.00 per share.
Graham Parry serves as Chief Scientific Officer at Electra Therapeutics, Inc. (ETRA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Graham Parry holds the position of Chief Scientific Officer at Electra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Graham Parry has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Graham Parry was on Sep 21, 2026, when they sold $0 worth of ETRA shares. This transaction involved 85,504 shares at N/A per share.
Graham Parry currently owns 85,504 shares of Electra Therapeutics, Inc. (ETRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Graham Parry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Graham Parry has 2 Form 4 filings on record as an insider at Electra Therapeutics, Inc..
Set alerts for Graham Parry and 40,000+ other insiders.